This inventor holds 50 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Takeda Pharmaceutical Company Limited, Canon Kabushiki Kaisha, Tobira Therapeutics, Inc.. Active years: 2001-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2007)
- Toride, JP (2008 - 2011)
- Ibaraki, JP (2003 - 2013)
- Osaka, JP (2001 - 2018)
- Gotemba, JP (2013 - 2021)
- Fujisawa, JP (2018 - 2023)
- Fujisawa Kanagawa, JP (2021 - 2023)
- Shizuoka, JP (2022 - 2023)
- Kanagawa, JP (2015 - 2024)
Company Filing History:
21 out of 1,229 
20 out of 93,136 
4 out of 8 
Years Active: 2001-2026
Areas of Expertise:
Sure, I'd be happy to help with that! Here's the article about inventor Masaki Seto based on the data provided:
Title: Unveiling the Innovative Mind of Masaki Seto
Introduction:
Masaki Seto, a distinguished inventor hailing from Gotemba, Japan, has etched his name in the realm of innovation with an impressive portfolio of 38 patents. Known for his groundbreaking work in the field of pharmaceuticals, Seto's latest patents showcase his prowess in developing compounds with vast therapeutic potentials.
Latest Patents:
1. Heterocyclic compound and use thereof: Seto's invention of a heterocyclic compound targeting the NMDA receptor NR2B subunit has significant implications for the prophylaxis and treatment of various neurological and psychiatric disorders such as major depression, bipolar disorder, and migraine.
2. Antibody-drug conjugates comprising a cyclic dinucleotide: Seto's formulation of a compound with STING agonistic activity opens new avenues for combatting STING-related diseases, offering promising prospects for their prevention and treatment.
Career Highlights:
Throughout his illustrious career, Masaki Seto has lent his expertise to esteemed organizations such as Canon Kabushiki Kaisha and Takeda Pharmaceutical Company Limited. His innovative contributions have not only propelled scientific advancements but have also positively impacted the healthcare industry.
Collaborations:
Seto's collaborative endeavors have been instrumental in his success, with notable associates like Mitsuru Shiraishi and Masanori Baba complementing his inventive spirit. Together, they have worked synergistically to bring forth cutting-edge solutions to complex medical challenges.
Conclusion:
In conclusion, Masaki Seto stands as a beacon of innovation, continuously pushing the boundaries of scientific exploration. His relentless pursuit of excellence and commitment to creating impactful solutions underscore his status as a visionary inventor shaping the future of healthcare and pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile